Inhibition of hemangioma development in a syngeneic mouse model correlates with bcl-2 suppression and the inhibition of Akt kinase activity

Hemangiomas and Vascular Malformations in Infants and Children

John B. Mulliken, Julie Glowacki · Plastic & Reconstructive Surgery · 1982 · 3.3K citations

Medicine, Child Health, Pediatrics +12

Cellular markers that distinguish the phases of hemangioma during infancy and childhood.

Kenkichi Takahashi, John B. Mulliken, Harry P. Kozakewich et al. · Journal of Clinical Investigation · 1994 · 649 citations · Full text

Medicine, Pathobiology, Pathology +16

Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas

O Enjolras, Michel Wassef, E. Mazoyer et al. · The Journal of Pediatrics · 1997 · 499 citations

Medicine, Pathology, Pediatrics +8

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy

Charles F. Barlow, Cedric J. Priebe, John B. Mulliken et al. · The Journal of Pediatrics · 1998 · 446 citations

Medicine, Neurology, Pediatrics +7

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Nikita Makretsov, Fiona M. Blows, K E Driver et al. · British Journal of Cancer · 2010 · 325 citations · Full text

Medicine, Oncology, Breast Oncology +15